Clinical Trial Update: Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial is investigating optimal timing of brain radiotherapy (delayed vs upfront) in treatment‑naïve non-small cell lung cancer patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Snippet

Sponsor: Joshua Palmer | Conditions: Lung Cancer, NSCLC | Phase 1, Phase 2 | Status: RECRUITING